Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc.
Your view on CELZ
Overview
What the company does, where it operates, and who runs it.
About Creative Medical Technology Holdings, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Timothy Warbington
- Headquarters
- 211 East Osborn Road, Phoenix, AZ, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Timothy Warbington
- Headquarters
- 211 East Osborn Road, Phoenix, AZ, US
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments.
The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Creative Medical Technology Holdings, Inc., and the rating behind it. CELZ last traded at $0.96; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Creative Medical Technology Holdings, Inc.. Starting points for Creative Medical Technology Holdings, Inc.: EPS -$1.63, beta 2.04 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Creative Medical Technology Holdings, Inc.. Creative Medical Technology Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Creative Medical Technology Holdings, Inc.. Trailing twelve-month EPS for Creative Medical Technology Holdings, Inc. stands at -$1.63. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Creative Medical Technology Holdings, Inc.. Creative Medical Technology Holdings, Inc. has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Creative Medical Technology Holdings, Inc. valued side by side against its closest peers. Creative Medical Technology Holdings, Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Creative Medical Technology Holdings, Inc., and how their positions are changing. At a $2.5M market value, institutional positions materially move Creative Medical Technology Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Creative Medical Technology Holdings, Inc. executives and directors. Shares of Creative Medical Technology Holdings, Inc. have traded between $1.69 and $6.90 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Creative Medical Technology Holdings, Inc.. Creative Medical Technology Holdings, Inc. is a $2.5M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Creative Medical Technology Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Creative Medical Technology Holdings, Inc.. Coverage tracks Creative Medical Technology Holdings, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.